Page last updated: 2024-10-17

aminocaproic acid and EHS Tumor

aminocaproic acid has been researched along with EHS Tumor in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anikin, IV1
Tyndyk, ML1
Zabezhinskiĭ, MA1
Popovich, IG1
Anisimov, VN1
Pliss, GB1

Other Studies

1 other study available for aminocaproic acid and EHS Tumor

ArticleYear
[Effect of epsilon-aminocaproic acid, cyclophosphamide and their combination on the growth of autochthonous sarcomas of mice induced by benzo(a)pyrene].
    Voprosy onkologii, 2014, Volume: 60, Issue:1

    Topics: Aminocaproic Acid; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; B

2014